Skip to main content
SpringerLink
Log in

Authors’ Reply to Urtasun et al.: “Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs”

  • Letter to the Editor
  • Published:
American Journal of Cardiovascular Drugs Aims and scope Submit manuscript

The Original Article was published on 18 May 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Urtasun MA, Prozzi GR, Marín GH, Buschiazzo HO, Cañás M, Dorati CM, Mordujovich P. Comment on: “Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs”. Am J Cardiovasc Drugs. 2017. doi:10.1007/s40256-017-0235-2.

  2. Thomas D, Ali Z, Zachariah S, et al. Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs. Am J Cardiovasc Drugs. Epub 28 Mar 2017. doi:10.1007/s40256-017-0223-6.

  3. Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–29.

    Article  CAS  PubMed  Google Scholar 

  4. FitzGerald GA. Imprecision: limitations to interpretation of a large randomized clinical trial. Circulation. 2017;135(2):113–5. doi:10.1161/CIRCULATIONAHA.116.026324.

    Article  PubMed  Google Scholar 

  5. Wendling P. PRECISION: Celecoxib Similar to Ibuprofen, Naproxen for CV Risk. Medscape. 2016. http://www.medscape.com/viewarticle/871835 Accessed 5 May 2017.

  6. Grosser T. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2017;376(14):1389. doi:10.1056/NEJMc1702534.

    Article  PubMed  Google Scholar 

  7. Nissen SE. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2017;376(14):1390. doi:10.1056/NEJMc1702534.

    Article  PubMed  Google Scholar 

  8. Coxib and traditional NSAID Trialists’ (CNT) Collaboration, Bhala N, Emberson J, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–79. doi:10.1016/S0140-6736(13)60900-9.

    Article  Google Scholar 

  9. Chan FKL, Ching JYL, Tse YK, Lam K, Wong GLH, Ng SC, Lee V, Au KWL, Cheong PK, Suen BY, Chan H, Kee KM, Lo A, Wong VWS, Wu JCY, Kyaw MH. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial. Lancet. Epub 11 April 2017. doi:10.1016/S0140-6736(17)30981-9.

  10. Gunter BR, Butler KA, Wallace RL, Smith SM, Harirforoosh S. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis. J Clin Pharm Ther. 2017;42(1):27–38. doi:10.1111/jcpt.12484.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, Gulf Medical University, Post Box: 4184, Ajman, United Arab Emirates

    Dixon Thomas, Seeba Zachariah & Kishore Gnana Sam Sundararaj

  2. Medical University of South Carolina Drug Information Center, Charleston, SC, USA

    Matthew Van Cuyk & Jason C. Cooper

Authors
  1. Dixon Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seeba Zachariah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kishore Gnana Sam Sundararaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthew Van Cuyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jason C. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dixon Thomas.

Ethics declarations

Funding

No external funding was used in the preparation of this reply.

Conflict of interest

Dixon Thomas, Seeba Zachariah, Kishore Gnana Sam Sundararaj, Matthew Van Cuyk, and Jason C. Cooper have no potential conflicts of interest that might be relevant to this reply.

Additional information

The original article is available at doi:10.1007/s40256-017-0223-6.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thomas, D., Zachariah, S., Sundararaj, K.G.S. et al. Authors’ Reply to Urtasun et al.: “Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs”. Am J Cardiovasc Drugs 17, 497–498 (2017). https://doi.org/10.1007/s40256-017-0236-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40256-017-0236-1

Search

Navigation